Shakya S, Shrestha A, Robinson S, Randall S, Mnatzaganian G, Brown H
BMJ Open. 2025; 15(1):e084917.
PMID: 39842921
PMC: 11784380.
DOI: 10.1136/bmjopen-2024-084917.
Li M, Wang B, Wang L, Tong L, Zhao G, Wang B
Lipids Health Dis. 2024; 23(1):292.
PMID: 39261844
PMC: 11389117.
DOI: 10.1186/s12944-024-02274-y.
Hughes M, Chico T
Sensors (Basel). 2023; 23(19).
PMID: 37836984
PMC: 10575134.
DOI: 10.3390/s23198154.
AlHajri N, Rustom M, Adegbile A, Ahmed W, Kilidar S, Afify N
Int J Mol Sci. 2022; 23(19).
PMID: 36232723
PMC: 9569471.
DOI: 10.3390/ijms231911421.
Ng S, Naqvi D, Bingcang J, Cruz G, Nose R, Lloyd G
Echo Res Pract. 2022; 9(1):8.
PMID: 36104742
PMC: 9473732.
DOI: 10.1186/s44156-022-00009-2.
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study.
Khan M, Hashim M, Mustafa H, Baniyas M, Al Suwaidi S, AlKatheeri R
Cureus. 2020; 12(7):e9349.
PMID: 32742886
PMC: 7384703.
DOI: 10.7759/cureus.9349.
Relative diagnostic, prognostic and economic value of stress echocardiography versus exercise electrocardiography as initial investigation for the detection of coronary artery disease in patients with new onset suspected angina.
Zacharias K, Ahmadvazir S, Ahmed A, Shah B, Acosta D, Senior R
Int J Cardiol Heart Vasc. 2017; 7:124-130.
PMID: 28785660
PMC: 5497249.
DOI: 10.1016/j.ijcha.2015.03.008.
Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study.
Kang J, Bennell M, Qiu F, Knudtson M, Austin P, Ko D
CMAJ Open. 2016; 4(3):E409-E416.
PMID: 27730104
PMC: 5047799.
DOI: 10.9778/cmajo.20150138.
Economic evaluation of trimetazidine in the management of chronic stable angina in Greece.
Kourlaba G, Gourzoulidis G, Andrikopoulos G, Tsioufis K, Beletsi A, Maniadakis N
BMC Health Serv Res. 2016; 16(1):520.
PMID: 27678370
PMC: 5039874.
DOI: 10.1186/s12913-016-1779-6.
Direct medical cost of newly diagnosed stable coronary artery disease in Hong Kong.
Lee V, Lam Y, Yuen A, Cheung S, Yu C, Yan B
Heart Asia. 2016; 5(1):1-6.
PMID: 27326062
PMC: 4832635.
DOI: 10.1136/heartasia-2012-010168.
Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.
Kourlaba G, Vlachopoulos C, Parissis J, Kanakakis J, Gourzoulidis G, Maniadakis N
BMC Health Serv Res. 2015; 15:566.
PMID: 26684327
PMC: 4683812.
DOI: 10.1186/s12913-015-1228-y.
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Coleman C, Freemantle N, Kohn C
BMJ Open. 2015; 5(11):e008861.
PMID: 26546142
PMC: 4636621.
DOI: 10.1136/bmjopen-2015-008861.
A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial.
Devi R, Powell J, Singh S
J Med Internet Res. 2014; 16(9):e186.
PMID: 25217464
PMC: 4180351.
DOI: 10.2196/jmir.3340.
Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting.
Kempf J, Buysman E, Brixner D
Am Health Drug Benefits. 2014; 4(6):353-61.
PMID: 25126362
PMC: 4105734.
Impact of self-management interventions on stable angina symptoms and health-related quality of life: a meta-analysis.
McGillion M, OKeefe-McCarthy S, Carroll S, Victor J, Cosman T, Cook A
BMC Cardiovasc Disord. 2014; 14:14.
PMID: 24483947
PMC: 3945741.
DOI: 10.1186/1471-2261-14-14.
The anti-ischemic and anti-anginal properties of statins.
Lardizabal J, Deedwania P
Curr Atheroscler Rep. 2010; 13(1):43-50.
PMID: 21107759
PMC: 3018271.
DOI: 10.1007/s11883-010-0147-y.
The conundrum of detecting stable angina pectoris in the community setting.
Russell M, Williams M, May E, Stewart S
Nat Rev Cardiol. 2009; 7(2):106-13.
PMID: 20027189
DOI: 10.1038/nrcardio.2009.226.
Effectiveness of Psychoeducational Interventions for Improving Symptoms, Health-Related Quality of Life, and Psychological well Being in Patients with Stable Angina.
McGillion M, Arthur H, Victor J, Watt-Watson J, Cosman T
Curr Cardiol Rev. 2009; 4(1):1-11.
PMID: 19924272
PMC: 2774580.
DOI: 10.2174/157340308783565393.
Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.
McGillion M, LAllier P, Arthur H, Watt-Watson J, Svorkdal N, Cosman T
Can J Cardiol. 2009; 25(7):399-401.
PMID: 19584968
PMC: 2723022.
DOI: 10.1016/s0828-282x(09)70501-x.
A review of the cost of cardiovascular disease.
Tarride J, Lim M, DesMeules M, Luo W, Burke N, OReilly D
Can J Cardiol. 2009; 25(6):e195-202.
PMID: 19536390
PMC: 2722492.
DOI: 10.1016/s0828-282x(09)70098-4.